PRTA - Prothena Corp Net earnings per share (EPS TTM)
Prothena Corporation (PRTA) relies on powerful patents in Alzheimer's therapy and alliances with industry behemoths. Net income per share over the last four quarters demonstrates local dynamics, where the value -0.47 describes the current level. However, colossal R&D expenditures and strict FDA oversight create barriers, while geopolitical tensions in the US and Ireland complicate component logistics.
Summary analytical data breakdowns for Prothena Corp (PRTA)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital Prothena Corporation|PRTA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Prothena Biosciences|PRTA - Aggregate Debt Obligations|Debts to Book Capitalization Prothena Corporation plc|PRTA - Company Long-Term Liabilities|Company Short-Term Debt Prothena|Quick Liquidity prothena.com
- net income and valuation multiples indicators:
PRTA - Final Profit|Expected Profit Prothena Corporation|PRTA - Market Cap to Net Income|Future Price to Earnings Prothena|PRTA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Prothena Corporation plc|PRTA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Prothena|PRTA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months prothena.com|PRTA - Net earnings per one share growth for the current year|Earnings growth forecast for next year Prothena Corporation
- revenue and sales proceeds data:
General company analysis:prothena.com (PRTA)
Retaining key neurobiologists through stock option programs directly impacts capital dilution, which is critical when calculating net earnings per share for Prothena Corporation (PRTA). By analyzing the rolling 12-month EPS, an investor sees the final annual financial result divided by the number of shares, where steady growth confirms effective resource management and the minimization of investment freeze risks.
Competitor analysis
BIIB: Net earnings per share for the last 12 months|neurocrine.com - Earnings per share for the last four quarters|RGC: Net earnings per share (EPS TTM)|Axsome - Earnings per share for the trailing year|ACAD (ACADIA Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Xenon Corp XENE|Earnings per share for the last twelve months Viking Therapeutics (VKTX)|supernus.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CPRX (Catalyst Pharmaceuticals, Inc.)|Net earnings per share (EPS TTM) Denali DNLI|HRMY: Net earnings per share for the last 12 months|Earnings per share for the trailing year BHVN (Biohaven Corp)|AMLX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months trevitherapeutics.com|Earnings per share for the last twelve months Praxis Precision Medicines, Inc.|Net earnings per one share for the last twelve months Anavex AVXL|Earnings per share for the last twelve months CeriBell Corp (CBLL)|ALEC (alector.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Annexon, Inc. ANNX|OMER (Omeros Corp) - Earnings per one share for the last 12 months|NGNE - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune S.A.|Voyager Pharma (VYGR) - Earnings per share for the last twelve months|Neumora Corp - Earnings per share for the trailing year|SCLX (Scilex Holding Company) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) tevogen.com|Net earnings per share for the last 12 months ACOG (Alpha Cognition)|Earnings per share for the last four quarters CGTX|Net earnings per share (EPS TTM) IKT (Inhibikase)|Net earnings per share for the last four quarters Cassava Pharma (SAVA)|ASRT - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Coya Therapeutics, Inc.|vistagen.com (VTGN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharma|CervoMed Corporation - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Alterity Therapeutics (ATHE)|CLNN (clene.com) - Earnings per share for the trailing year|PepGen - Net earnings per share for the last 12 months|Earnings per share for the last four quarters JUNS (Jupiter Neurosciences, Inc.)|Relmada - Net earnings per share (EPS TTM)|ANVS - Net earnings per share (EPS TTM)|gracetx.com (GRCE) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AIFF|KLTO (ANEW Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NeuroSense Therapeutics, Ltd. NRSN|Net earnings per share for the last 12 months RVPH (Reviva Pharmaceuticals Holdings)|Net earnings per share (EPS TTM) metaviatx.com (MTVA)|Earnings per share for the last twelve months NeurAxis, Inc. NRXS|Earnings per share for the trailing year HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics Inc.|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ATHA (Athira Pharma Corp)|Earnings per share for the last twelve months Addex Therapeutics|ALZN: Earnings per share for the trailing year|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|PTIX - Net earnings per one share for the last twelve months|Pasithea Therapeutics Corp. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CRGT (Cortigent Inc)|Avenue Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BCLI (brainstorm-cell.com)|CARA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Chromocell Therapeutics Corp (CHRO)|Earnings per share for the last twelve months Eliem Therapeutics, Inc.|Earnings per share for the last 12 months ITCI (Intra-Cellular)|Net earnings per share (EPS TTM) LBPH|Net earnings per share (EPS TTM) marinuspharma.com (MRNS)|NKGen Biotech - Net earnings per share for the last 12 months|Earnings per share for the trailing year NRBO|Sage Therapeutics, Inc - Net earnings per share (EPS TTM)|Synaptogenix, Inc (SNPX) - Net earnings per share for the last 12 months|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Vigil Neuroscience, Inc. (VIGL)|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year
